Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms

Stopped Terminated due to unfavorable risk-benefit ratio of investigational regimen.

Conditions

• Myeloid Neoplasm
• Recurrent Acute Myeloid Leukemia
• Refractory Acute Myeloid Leukemia

Interventions

• DRUG: Cladribine
• DRUG: Cytarabine
• BIOLOGICAL: Recombinant Granulocyte Colony-Stimulating Factor
• DRUG: Mitoxantrone

Sponsor

University of Washington